A system of managing the sterilisation of empty flexible pouches (1) provides applying sacrificial closures (200) to the empty pouches, loading the empty provisional closed pouches to be sterilised on a transport device (300) for the collective transportation, performing the sterilisation of the transport device (300) carrying the empty provisional closed pouches, and finally separating, in a sterile chamber, the sacrificial closures (200) from the pouches, filling and applying a tamper-proof cap (100).

Described herein are sealable, breathable bags for packaging, storing, and transporting fresh fruit in boxes. The bags protects the fruit from outside contaminants while maintaining a modified atmosphere environment around the fruit to preserve the freshness of the fruit. Furthermore, the bags are constructed in such a way that they have a flattened closed configuration and an fully opened configuration that allows them to efficiently fit into a generally cuboid, open-topped packaging box to be filled with fresh fruit and then seal around the fruit in the box, such as by sliding a slider across an upper closure of the bag.

Described herein are sealable, breathable bags for packaging, storing, and transporting fresh fruit in boxes. The bags protects the fruit from outside contaminants while maintaining a modified atmosphere environment around the fruit to preserve the freshness of the fruit. Furthermore, the bags are constructed in such a way that they have a flattened closed configuration and an fully opened configuration that allows them to efficiently fit into a generally cuboid, open-topped packaging box to be filled with fresh fruit and then seal around the fruit in the box, such as by sliding a slider across an upper closure of the bag.

This relates to an amorphous form of daclatasvir and its salts and process for preparation thereof. In particular, it relates to an amorphous form of daclatasvir and daclatasvir dihydrochloride. It also relates to pharmaceutical compositions comprising an amorphous form of daclatasvir or daclatasvir dihydrochloride for oral administration for treatment of Hepatitis C virus (HCV).

Described is a device for feeding and dosing infusion or extraction product of a machine (100) for making filter bags (S) containing the infusion or extraction product comprising a space (2) for containing infusion or extraction product defined by an outer lateral wall (3) and by an inner lateral wall (4) comprising openings (7) for the passage of the product; a feeding chamber (6) made inside the inner lateral wall (4), communicating through the openings (7) with the containment space (2) and equipped with an outlet (8) leading outside the containment space (2); a shutter (9), which is movable inside the feeding chamber (6) at least between a closed lower end position (P1), wherein it occludes the openings (7), and an open upper end position (P2), wherein it allows the passage of the product from the containment space (2) to the feeding chamber (6) through the openings (7) towards the outlet (8) to fill the filter bags (S) being formed.

Described is a device for feeding and dosing infusion or extraction product of a machine (100) for making filter bags (S) containing the infusion or extraction product comprising a space (2) for containing infusion or extraction product defined by an outer lateral wall (3) and by an inner lateral wall (4) comprising openings (7) for the passage of the product; a feeding chamber (6) made inside the inner lateral wall (4), communicating through the openings (7) with the containment space (2) and equipped with an outlet (8) leading outside the containment space (2); a shutter (9), which is movable inside the feeding chamber (6) at least between a closed lower end position (P1), wherein it occludes the openings (7), and an open upper end position (P2), wherein it allows the passage of the product from the containment space (2) to the feeding chamber (6) through the openings (7) towards the outlet (8) to fill the filter bags (S) being formed.

The invention relates to an edible and biodegradable package material composition and uses thereof. Specifically, the invention relates to a package material composition comprising a polysaccharide component, a protein component, or a combination thereof, in order to produce a transformational package that is both edible and naturally biodegradable. The package material composition of the invention provides a structural integrity to serve a full range of uses for packaging and shipping of both wet and dry products.

The invention relates to an edible and biodegradable package material composition and uses thereof. Specifically, the invention relates to a package material composition comprising a polysaccharide component, a protein component, or a combination thereof, in order to produce a transformational package that is both edible and naturally biodegradable. The package material composition of the invention provides a structural integrity to serve a full range of uses for packaging and shipping of both wet and dry products.

A resealable package for mixing two or more components, comprising a base, walls that extend from said base, whereby said walls are joined to each other such that an overall volume is defined that is able to accept a quantity of fluid, a fluid solid or gas, a folding section that folds such that the overall volume of the package is reduced, and a resealable opening.

A resealable package for mixing two or more components, comprising a base, walls that extend from said base, whereby said walls are joined to each other such that an overall volume is defined that is able to accept a quantity of fluid, a fluid solid or gas, a folding section that folds such that the overall volume of the package is reduced, and a resealable opening.